Suchergebnisse - "Lu, Tianzhu"

PubPharm (62)

11

Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma

enthalten in: Rapid Communications in Mass Spectrometry | 2023

von Liao, Z. | Zhao, L. | Zhong, F. | +6

12

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology (London, England) | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

13

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

14

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

15

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype in lung adenocarcinoma

enthalten in: ResearchSquare.com | 2022

von Chen, R. | Wang, Z. | Lu, T. | +5

16

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma

enthalten in: The oncologist | 2022

von Lin, C. | Lin, K. | Zhang, B. | +7

17

Gypenosides inhibits the growth and induces apoptosis of glioma cells by promoting autophagy

enthalten in: ResearchSquare.com | 2022

von Liu, H. | Ji, Y. | Lv, Q. | +12

18

Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2022

von Guo, Q. | Xiao, N. | Xu, H. | +8

19

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis

enthalten in: Frontiers in genetics | 2022

von Zhang, Z. | Shen, X. | Tan, Z. | +11

20

High Expression of CKS2 Predicts Adverse Outcomes : A Potential Therapeutic Target for Glioma

enthalten in: Frontiers in immunology | 2022

von Yu, K. | Ji, Y. | Liu, M. | +7